GeneDx and PepGen Set for Critical Monday Earnings Amid Genomics Pivot
GeneDx (WGS) and PepGen (PEPG) are scheduled to release financial results on Monday, marking a pivotal moment for the clinical genomics and neuromuscular therapeutic sectors. Investors are looking for GeneDx to demonstrate a sustainable path to profitability through its whole genome sequencing volume, while PepGen's update will focus on its clinical pipeline and cash position.